In addition, Abeona has a proprietary vector platform, AIM™, for next generation product candidates. For more information, visit www.abeonatherapeutics.com. Investor Contact: Christine Silverstein Vice President, Investor Relations Abeona Therapeutics Inc. +1 (212) 786-6212 csilverstein@abeonatherapeutics.com Media Contact: Lynn Granito Berry & Company Public Relations +1 (212) 253-8881 lgranito@berrypr.com This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended, and that involve risks and uncertainties.